German Health Minister Attacks Drug Prices With Forced Rebates
This article was originally published in The Pink Sheet Daily
Executive Summary
Minister Roesler says he will impose rebates on patented drugs until pharma companies negotiate lower prices directly with insurers.
You may also be interested in...
Emerging Markets, Biosimilars May Enhance Suitors' Interest In ratiopharm
More than a year after being put up for sale, German generics firm ratiopharm is now said to have three serious suitors: generics giant Teva, Iceland's Actavis and Pfizer
Emerging Markets, Biosimilars May Enhance Suitors' Interest In ratiopharm
More than a year after being put up for sale, German generics firm ratiopharm is now said to have three serious suitors: generics giant Teva, Iceland's Actavis and Pfizer
Pricing Experiments: Pharmas Get Creative in Germany
As Germany's insurers try out new drug reimbursement tactics, innovative pharmas have responded with novel, brand-boosting payor deals of their own. The evolution of these payor-pharma deals in Germany should inform reimbursement strategies elsewhere--including in the US where similar trends are starting to emerge.